ARCA biopharma Competitors and Similar CompaniesClear all

ARCA biopharma's competitors and similar companies include Ionis Pharmaceuticals, Sylentis, AnGes and Rocket Pharmaceuticals.

	ARCA biopharma ARCA biopharma develops genetically-targeted therapies for cardiovascular diseases.	Ionis Pharmaceuticals Ionis Pharmaceuticals (formerly known as Isis Pharmaceuticals) is a company that discovers and develops RNA-targeted therapeutics.	Sylentis Sylentis is a biotechnology company focused on the development of ophthalmic drugs and therapies based on RNAi (gene silencing) technology.	AnGes AnGes is a biopharmaceutical company specializing in R&D and practical application of genetic medicine.	Rocket Pharmaceuticals Rocket Pharmaceuticals is a biotechnology company focused on seeking cures through molecular and gene therapy.
Founding Date	Founding Date 2009	Founding Date 1989	Founding Date 2006	Founding Date 1999	Founding Date 2018
Type	Type Public	Type Public	Type Private	Type Public	Type Public
Tags	Tags Healthcare biotech drug development genetics pharma	Tags Healthcare biotech drug development genetics pharma	Tags Healthcare biotech drug development genetics pharma	Tags Healthcare biotech drug development genetics pharma	Tags Healthcare biotech drug development genetics pharma
Locations	Locations Westminster, US HQ Westminster, US	Locations Carlsbad, US HQ Vancouver, CA Stuttgart, DE Dublin, IE Dublin, IE Lisboa, PT London, GB see more	Locations Tres Cantos, ES HQ Madrid, ES Mountain View, US	Locations Ibaraki, JP HQ Fujisawa, JP Ibaraki, JP Kawasaki, JP Minato City, JP Bethesda, US	Locations East Windsor, US HQ New York, US
Employees	Employees 940% decrease	Employees 1,40231% increase	Employees 51	Employees 5562% decrease	Employees 5716% increase
Valuation ($)	Valuation ($) 34.8 m	Valuation ($) 6.3 b	Valuation ($) N/A	Valuation ($) 78.3 m	Valuation ($) 1.6 b
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $943.7m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) ¥874.1m (FY, 2025)	Revenue (est.) N/A
Cost of goods	Cost of goods N/A	Cost of goods $15.9m (FY, 2025)	Cost of goods N/A	Cost of goods ¥499.9m (FY, 2025)	Cost of goods $1.1m (FY, 2025)
Gross profit	Gross profit N/A	Gross profit $927.8m (FY, 2025)	Gross profit N/A	Gross profit ¥374.2m (FY, 2025)	Gross profit N/A
Net income	Net income ($105.4m) (FY, 2025)	Net income ($381.4m) (FY, 2025)	Net income N/A	Net income (¥5.1b) (FY, 2025)	Net income ($223.1m) (FY, 2025)